Molecular evolution of human species D adenoviruses

Infection, Genetics and Evolution

Volumn 11, Issue 6, 2011, Pages 1208-1217

  Robinson, Christopher M ^a,d   Seto, Donald ^b   Jones, Morris S ^c   Dyer, David W ^d   Chodosh, James ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b GEORGE MASON UNIVERSITY   (United States)

^c VIRAL AND RICKETTSIAL DISEASE LABORATORY   (United States)

^d UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

HAdV D; Human adenovirus; Recombination

Indexed keywords

CAPSID PROTEIN; FIBER PROTEIN; HEXON PROTEIN; PENTON BASE PROTEIN; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN;

BINDING SITE; GENETIC CONSERVATION; GENETIC VARIABILITY; GENOME ANALYSIS; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN ADENOVIRUS; HUMAN ADENOVIRUS D; INVERTED TERMINAL REPEAT; MOLECULAR EVOLUTION; MOLECULAR PHYLOGENY; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DOMAIN; REVIEW; SEQUENCE ANALYSIS; VIRUS IDENTIFICATION; VIRUS ISOLATION; VIRUS MORPHOLOGY; VIRUS TRANSCRIPTION;

ADENOVIRUSES, HUMAN; EVOLUTION, MOLECULAR; GENETIC VARIATION; GENOME, VIRAL; HUMANS; PHYLOGENY; RECOMBINATION, GENETIC; SEQUENCE ALIGNMENT;

ADENOVIRIDAE; DNA VIRUSES; HUMAN ADENOVIRUS; HUMAN ADENOVIRUS D; VERTEBRATA;

EID: 79960413039     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2011.04.031     Document Type: Review

References (127)

1. Abbink P., Lemckert A.A., Ewald B.A., Lynch D.M., Denholtz M., Smits S., Holterman L., Damen I., Vogels R., Thorner A.R., O'Brien K.L., Carville A., Mansfield K.G., Goudsmit J., Havenga M.J., Barouch D.H. Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D. J. Virol. 2007, 81:4654-4663.
2. Adrian T., Wigand R. Adenovirus 3-7, an intermediate strain of subgenus B. Intervirology 1986, 26:202-206.
3. Adrian T., Bastian B., Benoist W., Hierholzer J.C., Wigand R. Characterization of adenovirus 15/H9 intermediate strains. Intervirology 1985, 23:15-22.
4. Adrian T., Wigand R., Wadell G. Serological and biochemical characteristics of intermediate adenovirus strains of subgenus D. Arch. Virol. 1987, 97:347-357.
5. Aoki K., Ishiko H., Konno T., Shimada Y., Hayashi A., Kaneko H., Ohguchi T., Tagawa Y., Ohno S., Yamazaki S. Epidemic keratoconjunctivitis due to the novel hexon-chimeric-intermediate 22,37/H8 human adenovirus. J. Clin. Microbiol. 2008, 46:3259-3269.
6. Arnberg N., Edlund K., Kidd A.H., Wadell G. Adenovirus type 37 uses sialic acid as a cellular receptor. J. Virol. 2000, 74:42-48.
7. Arnberg N., Pring-Akerblom P., Wadell G. Adenovirus type 37 uses sialic acid as a cellular receptor on Chang C cells. J. Virol. 2002, 76:8834-8841.
8. Arnold J., Janoska M., Kajon A.E., Metzgar D., Hudson N.R., Torres S., Harrach B., Seto D., Chodosh J., Jones M.S. Genomic characterization of human adenovirus 36, a putative obesity agent. Virus Res. 2010, 149:152-161.
9. Atkinson R.L., Dhurandhar N.V., Allison D.B., Bowen R.L., Israel B.A., Albu J.B., Augustus A.S. Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids. Int. J. Obes. (Lond.) 2005, 29:281-286.
10. Bell S.D., Mc C.D., Murray E.S., Chang R.S., Snyder J.C. Adenoviruses isolated from Saudi Arabia I. Epidemiologic features. Am. J. Trop. Med. Hyg. 1959, 8:492-500.
11. Benedict C.A., Norris P.S., Prigozy T.I., Bodmer J.L., Mahr J.A., Garnett C.T., Martinon F., Tschopp J., Gooding L.R., Ware C.F. Three adenovirus E3 proteins cooperate to evade apoptosis by tumor necrosis factor-related apoptosis-inducing ligand receptor-1 and -2. J. Biol. Chem. 2001, 276:3270-3278.
12. Bergelson J.M., Cunningham J.A., Droguett G., Kurt-Jones E.A., Krithivas A., Hong J.S., Horwitz M.S., Crowell R.L., Finberg R.W. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 1997, 275:1320-1323.
13. Berget S.M., Moore C., Sharp P.A. Spliced segments at the 5′ terminus of adenovirus 2 late mRNA. Proc. Natl. Acad. Sci. U.S.A. 1977, 74:3171-3175.
14. Bhat B.M., Wold W.S. Genetic analysis of mRNA synthesis in adenovirus region E3 at different stages of productive infection by RNA-processing mutants. J. Virol. 1986, 60:54-63.
15. Boulay J.L., Perruchoud A.P., Reuter J., Bolliger C., Herrmann R., Rochlitz C. P21 gene expression as an indicator for the activity of adenovirus-p53 gene therapy in non-small cell lung cancer patients. Cancer Gene Ther. 2000, 7:1215-1219.
16. Boursnell M.E., Mautner V. Recombination in adenovirus: crossover sites in intertypic recombinants are located in regions of homology. Virology 1981, 112:198-209.
17. Burgert H.G., Blusch J.H. Immunomodulatory functions encoded by the E3 transcription unit of adenoviruses. Virus Genes 2000, 21:13-25.
18. Burgert H.G., Maryanski J.L., Kvist S. E3/19K protein of adenovirus type 2 inhibits lysis of cytolytic T lymphocytes by blocking cell-surface expression of histocompatibility class I antigens. Proc. Natl. Acad. Sci. U.S.A. 1987, 84:1356-1360.
19. Chiu C.Y., Wu E., Brown S.L., Von Seggern D.J., Nemerow G.R., Stewart P.L. Structural analysis of a fiber-pseudotyped adenovirus with ocular tropism suggests differential modes of cell receptor interactions. J. Virol. 2001, 75:5375-5380.
20. Chow L.T., Broker T.R. The spliced structures of adenovirus 2 fiber message and the other late mRNAs. Cell 1978, 15:497-510.
21. Chow L.T., Gelinas R.E., Broker T.R., Roberts R.J. An amazing sequence arrangement at the 5′ ends of adenovirus 2 messenger RNA. Cell 1977, 12:1-8.
22. Chow L.T., Roberts J.M., Lewis J.B., Broker T.R. A map of cytoplasmic RNA transcripts from lytic adenovirus type 2, determined by electron microscopy of RNA:DNA hybrids. Cell 1977, 11:819-836.
23. Chow L.T., Broker T.R., Lewis J.B. Complex splicing patterns of RNAs from the early regions of adenovirus-2. J. Mol. Biol. 1979, 134:265-303.
24. Chow L.T., Lewis J.B., Broker T.R. RNA transcription and splicing at early and intermediate times after adenovirus-2 infection. Cold Spring Harb. Symp. Quant. Biol. 1980, 44(Pt 1):401-414.
25. Chroboczek J., Ruigrok R.W., Cusack S. Adenovirus fiber. Curr. Top. Microbiol. Immunol. 1995, 199(Pt 1):163-200.
26. Chu W., Pavan-Langston D. Ocular surface manifestations of the major viruses. Int. Ophthalmol. Clin. 1979, 19:135-167.
27. Crawford-Miksza L., Schnurr D.P. Analysis of 15 adenovirus hexon proteins reveals the location and structure of seven hypervariable regions containing serotype-specific residues. J. Virol. 1996, 70:1836-1844.
28. Crawford-Miksza L.K., Nang R.N., Schnurr D.P. Strain variation in adenovirus serotypes 4 and 7a causing acute respiratory disease. J. Clin. Microbiol. 1999, 37:1107-1112.
29. Crystal R.G., McElvaney N.G., Rosenfeld M.A., Chu C.S., Mastrangeli A., Hay J.G., Brody S.L., Jaffe H.A., Eissa N.T., Danel C. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat. Genet. 1994, 8:42-51.
30. Curlin M.E., Huang M.L., Lu X., Celum C.L., Sanchez J., Selke S., Baeten J.M., Zuckerman R.A., Erdman D.D., Corey L. Frequent detection of human adenovirus from the lower gastrointestinal tract in men who have sex with men. PLoS ONE 2010, 5:e11321.
31. Cypel M., Liu M., Rubacha M., Yeung J.C., Hirayama S., Anraku M., Sato M., Medin J., Davidson B.L., de Perrot M., Waddell T.K., Slutsky A.S., Keshavjee S. Functional repair of human donor lungs by IL-10 gene therapy. Sci. Transl. Med. 2009, 1(4):ra9.
32. Darr S., Madisch I., Hofmayer S., Rehren F., Heim A. Phylogeny and primary structure analysis of fiber shafts of all human adenovirus types for rational design of adenoviral gene-therapy vectors. J. Gen. Virol. 2009, 90:2849-2854.
33. Davison A.J., Benko M., Harrach B. Genetic content and evolution of adenoviruses. J. Gen. Virol. 2003, 84:2895-2908.
34. de Jong J.C., Wigand R., Wadell G., Keller D., Muzerie C.J., Wermenbol A.G., Schaap G.J. Adenovirus 37: identification and characterization of a medically important new adenovirus type of subgroup D. J. Med. Virol. 1981, 7:105-118.
35. De Jong J.C., Wermenbol A.G., Verweij-Uijterwaal M.W., Slaterus K.W., Wertheim-Van Dillen P., Van Doornum G.J., Khoo S.H., Hierholzer J.C. Adenoviruses from human immunodeficiency virus-infected individuals, including two strains that represent new candidate serotypes Ad50 and Ad51 of species B1 and D, respectively. J. Clin. Microbiol. 1999, 37:3940-3945.
36. Deryckere F., Burgert H.G. Early region 3 of adenovirus type 19 (subgroup D) encodes an HLA-binding protein distinct from that of subgroups B and C. J. Virol. 1996, 70:2832-2841.
37. Dhurandhar N.V., Israel B.A., Kolesar J.M., Mayhew G.F., Cook M.E., Atkinson R.L. Increased adiposity in animals due to a human virus. Int. J. Obes. Relat. Metab. Disord. 2000, 24:989-996.
38. Dingle J.H., Langmuir A.D. Epidemiology of acute, respiratory disease in military recruits. Am. Rev. Respir. Dis. 1968, 97(Suppl.):1-65.
39. Engelmann I., Madisch I., Pommer H., Heim A. An outbreak of epidemic keratoconjunctivitis caused by a new intermediate adenovirus 22/H8 identified by molecular typing. Clin. Infect. Dis. 2006, 43:e64-e66.
40. Feuerbach D., Etteldorf S., Ebenau-Jehle C., Abastado J.P., Madden D., Burgert H.G. Identification of amino acids within the MHC molecule important for the interaction with the adenovirus protein E3/19K. J. Immunol. 1994, 153:1626-1636.
41. Fox J.P., Hall C.E., Cooney M.K. The Seattle virus watch. VII. Observations of adenovirus infections. Am. J. Epidemiol. 1977, 105:362-386.
42. Garnett C.T., Erdman D., Xu W., Gooding L.R. Prevalence and quantitation of species C adenovirus DNA in human mucosal lymphocytes. J. Virol. 2002, 76:10608-10616.
43. Gene Therapy Clinical Trials Worldwide J. Gene Med. 2010, (accessed 27.01.11). http://www.abedia.com/wiley/vectors.php.
44. Grodzicker T., Williams J., Sharp P., Sambrook J. Physical mapping of temperature-sensitive mutations of adenoviruses. Cold Spring Harb. Symp. Quant. Biol. 1975, 39(Pt 1):439-446.
45. Hawkins L.K., Wold W.S. A 12,500MW protein is coded by region E3 of adenovirus. Virology 1992, 188:486-494.
46. Hedman M., Hartikainen J., Syvanne M., Stjernvall J., Hedman A., Kivela A., Vanninen E., Mussalo H., Kauppila E., Simula S., Narvanen O., Rantala A., Peuhkurinen K., Nieminen M.S., Laakso M., Yla-Herttuala S. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT). Circulation 2003, 107:2677-2683.
47. Henquell C., Boeuf B., Mirand A., Bacher C., Traore O., Dechelotte P., Labbe A., Bailly J.L., Peigue-Lafeuille H. Fatal adenovirus infection in a neonate and transmission to health-care workers. J. Clin. Virol. 2009, 45:345-348.
48. Hierholzer J.C., Torrence A.E., Wright P.F. Generalized viral illness caused by an intermediate strain of adenovirus (21/H21+35). J. Infect. Dis. 1980, 141:281-288.
49. Hierholzer J.C., Kemp M.C., Gary G.W., Spencer H.C. New human adenovirus associated with respiratory illness: candidate adenovirus type 39. J. Clin. Microbiol. 1982, 16:15-21.
50. Hierholzer J.C., Adrian T., Anderson L.J., Wigand R., Gold J.W. Analysis of antigenically intermediate strains of subgenus B and D adenoviruses from AIDS patients. Arch. Virol. 1988, 103:99-115.
51. Hierholzer J.C., Wigand R., Anderson L.J., Adrian T., Gold J.W. Adenoviruses from patients with AIDS: a plethora of serotypes and a description of five new serotypes of subgenus D (types 43-47). J. Infect. Dis. 1988, 158:804-813.
52. Hierholzer J.C., Stone Y.O., Broderson J.R. Antigenic relationships among the 47 human adenoviruses determined in reference horse antisera. Arch. Virol. 1991, 121:179-197.
53. Hilgendorf A., Lindberg J., Ruzsics Z., Honing S., Elsing A., Lofqvist M., Engelmann H., Burgert H.G. Two distinct transport motifs in the adenovirus E3/10.4-14.5 proteins act in concert to down-modulate apoptosis receptors and the epidermal growth factor receptor. J. Biol. Chem. 2003, 278:51872-51884.
54. Hilleman M.R., Werner J.H. Recovery of new agent from patients with acute respiratory illness. Proc. Soc. Exp. Biol. Med. 1954, 85:183-188.
55. Horvath J., Palkonyay L., Weber J. Group C adenovirus DNA sequences in human lymphoid cells. J. Virol. 1986, 59:189-192.
56. Horwitz M.S., Valderrama G., Hatcher V., Korn R., deJong P., Spigland I. Characterization of adenovirus isolates from AIDS patients. Ann. N. Y. Acad. Sci. 1984, 437:161-174.
57. Ishiko H., Shimada Y., Konno T., Hayashi A., Ohguchi T., Tagawa Y., Aoki K., Ohno S., Yamazaki S. Novel human adenovirus causing nosocomial epidemic keratoconjunctivitis. J. Clin. Microbiol. 2008, 46:2002-2008.
58. Jager L., Ehrhardt A. Emerging adenoviral vectors for stable correction of genetic disorders. Curr. Gene Ther. 2007, 7:272-283.
59. Jawetz E., Kimura S., Nicholas A.N., Thygeson P., Hanna L. new type of APC virus from epidemic keratoconjunctivitis. Science 1955, 122:1190-1191.
60. Jones M.S., Harrach B., Ganac R.D., Gozum M.M., Dela Cruz W.P., Riedel B., Pan C., Delwart E.L., Schnurr D.P. New adenovirus species found in a patient presenting with gastroenteritis. J. Virol. 2007, 81:5978-5984.
61. Kahl C.A., Bonnell J., Hiriyanna S., Fultz M., Nyberg-Hoffman C., Chen P., King C.R., Gall J.G. Potent immune responses and in vitro pro-inflammatory cytokine suppression by a novel adenovirus vaccine vector based on rare human serotype 28. Vaccine 2010, 28:5691-5702.
62. Kajon A.E., Dickson L.M., Murtagh P., Viale D., Carballal G., Echavarria M. Molecular characterization of an adenovirus 3-16 intertypic recombinant isolated in Argentina from an infant hospitalized with acute respiratory infection. J. Clin. Microbiol. 2010, 48:1494-1496.
63. Kaneko H., Iida T., Ishiko H., Ohguchi T., Ariga T., Tagawa Y., Aoki K., Ohno S., Suzutani T. Analysis of the complete genome sequence of epidemic keratoconjunctivitis-related human adenovirus type 8, 19, 37 and a novel serotype. J. Gen. Virol. 2009, 90:1471-1476.
64. Kaneko H., Aoki K., Ohno S., Ishiko H., Fujimoto T., Kikuchi M., Harada S., Gonzalez G., Koyanagi K.O., Watanabe H., Suzutani T. Complete genome analysis of a novel intertypic recombinant human adenovirus causing epidemic keratoconjunctivitis in Japan. J. Clin. Microbiol. 2010.
65. Kaneko H., Suzutani T., Aoki K., Kitaichi N., Ishida S., Ishiko H., Ohashi T., Okamoto S., Nakagawa H., Hinokuma R., Asato Y., Oniki S., Hashimoto T., Iida T., Ohno S. Epidemiological and virological features of epidemic keratoconjunctivitis due to new human adenovirus type 54 in Japan. Br. J. Ophthalmol. 2011, 95:32-36.
66. Kim Y.J., Schmidt N.J., Mirkovic R.R. Isolation of an intermediate type of adenovirus from a child with fulminant hepatitis. J. Infect. Dis. 1985, 152:844.
67. Kojaoghlanian T., Flomenberg P., Horwitz M.S. The impact of adenovirus infection on the immunocompromised host. Rev. Med. Virol. 2003, 13:155-171.
68. Lasaro M.O., Ertl H.C. New insights on adenovirus as vaccine vectors. Mol. Ther. 2009, 17:1333-1339.
69. Lemckert A.A., Grimbergen J., Smits S., Hartkoorn E., Holterman L., Berkhout B., Barouch D.H., Vogels R., Quax P., Goudsmit J., Havenga M.J. Generation of a novel replication-incompetent adenoviral vector derived from human adenovirus type 49: manufacture on PER.C6 cells, tropism and immunogenicity. J. Gen. Virol. 2006, 87:2891-2899.
70. Li Y., Wold W.S. Identification and characterization of a 30K protein (Ad4E3-30K) encoded by the E3 region of human adenovirus type 4. Virology 2000, 273:127-138.
71. Li E., Brown S.L., Stupack D.G., Puente X.S., Cheresh D.A., Nemerow G.R. Integrin alpha(v)beta1 is an adenovirus coreceptor. J. Virol. 2001, 75:5405-5409.
72. Lippin Y., Dranitzki-Elhalel M., Brill-Almon E., Mei-Zahav C., Mizrachi S., Liberman Y., Iaina A., Kaplan E., Podjarny E., Zeira E., Harati M., Casadevall N., Shani N., Galun E. Human erythropoietin gene therapy for patients with chronic renal failure. Blood 2005, 106:2280-2286.
73. Lu X., Erdman D.D. Molecular typing of human adenoviruses by PCR and sequencing of a partial region of the hexon gene. Arch. Virol. 2006, 151:1587-1602.
74. Lukashev A.N., Ivanova O.E., Eremeeva T.P., Iggo R.D. Evidence of frequent recombination among human adenoviruses. J. Gen. Virol. 2008, 89:380-388.
75. Macek V., Sorli J., Kopriva S., Marin J. Persistent adenoviral infection and chronic airway obstruction in children. Am. J. Respir. Crit. Care Med. 1994, 150:7-10.
76. Madisch I., Hofmayer S., Moritz C., Grintzalis A., Hainmueller J., Pring-Akerblom P., Heim A. Phylogenetic analysis and structural predictions of human adenovirus penton proteins as a basis for tissue-specific adenovirus vector design. J. Virol. 2007, 81:8270-8281.
77. Marin J., Jeler-Kacar D., Levstek V., Macek V. Persistence of viruses in upper respiratory tract of children with asthma. J. Infect. 2000, 41:69-72.
78. Matumoto M., Uchida S., Hoshika T. Isolation of an intermediate type of adenovirus from a fatal case of infantile pneumonia. Jpn. J. Exp. Med. 1958, 28:305-315.
79. Mautner V., Williams J., Sambrook J., Sharp P.A., Grodzicker T. The location of the genes coding for hexon and fiber proteins in adenovirus DNA. Cell 1975, 5:93-99.
80. Meinschad C., Winnacker E.L. Recombination in adenovirus. I. Analysis of recombinant viruses under non-selective conditions. J. Gen. Virol. 1980, 48:219-224.
81. Nilsson E.C., Storm R.J., Bauer J., Johansson S.M., Lookene A., Angstrom J., Hedenstrom M., Eriksson T.L., Frangsmyr L., Rinaldi S., Willison H.J., Domellof F.P., Stehle T., Arnberg N. The GD1a glycan is a cellular receptor for adenoviruses causing epidemic keratoconjunctivitis. Nat. Med. 2011, 17:105-109.
82. Norby E. Comparative studies on the soluble components of adenovirus types 9 and 15 and the intermediate strain 9-15. J. Virol. 1968, 2:1200-1210.
83. Parks W.P., Queiroga L.M., Melnick J.L., Pereira H.G. Recent adenovirus isolates exhibiting broad intratypic and intertypic antigenicity. Proc. Soc. Exp. Biol. Med. 1967, 125:498-503.
84. Phillips P.A., Harnett G.B., Gollow M.M. Adenovirus type 19 and a closely related new serotype in genital infection. Br. J. Vener. Dis. 1982, 58:131-132.
85. Pichla-Gollon S.L., Lin S.W., Hensley S.E., Lasaro M.O., Herkenhoff-Haut L., Drinker M., Tatsis N., Gao G.P., Wilson J.M., Ertl H.C., Bergelson J.M. Effect of preexisting immunity on an adenovirus vaccine vector: in vitro neutralization assays fail to predict inhibition by antiviral antibody in vivo. J. Virol. 2009, 83:5567-5573.
86. Reddy P.S., Ganesh S., Knowles N.J., Kaleko M., Connelly S., Bristol A. Complete sequence and organization of the human adenovirus serotype 46 genome. Virus Res. 2006, 116:119-128.
87. Robinson C.M., Shariati F., Gillaspy A.F., Dyer D.W., Chodosh J. Genomic and bioinformatics analysis of human adenovirus type 37: new insights into corneal tropism. BMC Genomics 2008, 9:213.
88. Robinson C.M., Rajaiya J., Walsh M.P., Seto D., Dyer D.W., Jones M.S., Chodosh J. Computational analysis of human adenovirus type 22 provides evidence for recombination among species D human adenoviruses in the penton base gene. J. Virol. 2009, 83:8980-8985.
89. Robinson C.M., Shariati F., Zaitshik J., Gillaspy A.F., Dyer D.W., Chodosh J. Human adenovirus type 19: genomic and bioinformatics analysis of a keratoconjunctivitis isolate. Virus Res. 2009, 139:122-126.
90. Robinson C.M., Singh G., Henquell C., Walsh M.P., Peigue-Lafeuille H., Seto D., Jones M.S., Dyer D.W., Chodosh J. Computational analysis and identification of an emergent human adenovirus pathogen implicated in a respiratory fatality. Virology 2011, 409:141-147.
91. Rosen L., Baron S., Bell J.A. Four newly recognized adenoviruses. Proc. Soc. Exp. Biol. Med. 1961, 107:434-437.
92. Rosen L., Hovis J.F., Bell J.A. Further observation on typing adenoviruses and a description of two possible additional serotypes. Proc. Soc. Exp. Biol. Med. 1962, 110:710-713.
93. Rowe W.P., Huebner R.J., Gilmore L.K., Parrott R.H., Ward T.G. Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture. Proc. Soc. Exp. Biol. Med. 1953, 84:570-573.
94. Ruzsics Z., Wagner M., Osterlehner A., Cook J., Koszinowski U., Burgert H.G. Transposon-assisted cloning and traceless mutagenesis of adenoviruses: development of a novel vector based on species D. J. Virol. 2006, 80:8100-8113.
95. Sambrook J., Williams J., Sharp P.A., Grodzicker T. Physical mapping of temperature-sensitive mutations of adenoviruses. J. Mol. Biol. 1975, 97:369-390.
96. Schnurr D., Dondero M.E. Two new candidate adenovirus serotypes. Intervirology 1993, 36:79-83.
97. Seto D., Chodosh J., Brister J.R., Jones M.S. Using the whole genome sequence to characterize and name human adenoviruses. J. Virol. 2011.
98. Smith J.G., Wiethoff C.M., Stewart P.L., Nemerow G.R. Adenovirus. Curr. Top. Microbiol. Immunol. 2010, 343:195-224.
99. Stevens D.A., Schaeffer M., Fox J.P., Brandt C.D., Romano M. Standardization and certification of reference antigens and antisera for 30 human adenovirus serotypes. Am. J. Epidemiol. 1967, 86:617-633.
100. Stewart P.L., Chiu C.Y., Huang S., Muir T., Zhao Y., Chait B., Mathias P., Nemerow G.R. Cryo-EM visualization of an exposed RGD epitope on adenovirus that escapes antibody neutralization. EMBO J. 1997, 16:1189-1198.
101. Stewart A.K., Lassam N.J., Quirt I.C., Bailey D.J., Rotstein L.E., Krajden M., Dessureault S., Gallinger S., Cappe D., Wan Y., Addison C.L., Moen R.C., Gauldie J., Graham F.L. Adenovector-mediated gene delivery of interleukin-2 in metastatic breast cancer and melanoma: results of a phase 1 clinical trial. Gene Ther. 1999, 6:350-363.
102. Swenson P.D., Lowens M.S., Celum C.L., Hierholzer J.C. Adenovirus types 2, 8, and 37 associated with genital infections in patients attending a sexually transmitted disease clinic. J. Clin. Microbiol. 1995, 33:2728-2731.
103. Takemori N. Genetic studies with tumorigenic adenoviruses. 3. Recombination in adenovirus type 12. Virology 1972, 47:157-167.
104. Thirion C., Lochmuller H., Ruzsics Z., Boelhauve M., Konig C., Thedieck C., Kutik S., Geiger C., Kochanek S., Volpers C., Burgert H.G. Adenovirus vectors based on human adenovirus type 19a have high potential for human muscle-directed gene therapy. Hum. Gene Ther. 2006, 17:193-205.
105. Toogood C.I., Crompton J., Hay R.T. Antipeptide antisera define neutralizing epitopes on the adenovirus hexon. J. Gen. Virol. 1992, 73(Pt 6):1429-1435.
106. Top F.H., Buescher E.L., Bancroft W.H., Russell P.K. Immunization with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7. J. Infect. Dis. 1971, 124:155-160.
107. Top F.H., Grossman R.A., Bartelloni P.J., Segal H.E., Dudding B.A., Russell P.K., Buescher E.L. Immunization with live types 7 and 4 adenovirus vaccines. I. Safety, infectivity, antigenicity, and potency of adenovirus type 7 vaccine in humans. J. Infect. Dis. 1971, 124:148-154.
108. van der Linden R.R., Haagmans B.L., Mongiat-Artus P., van Doornum G.J., Kraaij R., Kadmon D., Aguilar-Cordova E., Osterhaus A.D., van der Kwast T.H., Bangma C.H. Virus specific immune responses after human neoadjuvant adenovirus-mediated suicide gene therapy for prostate cancer. Eur. Urol. 2005, 48:153-161.
109. Vora G.J., Lin B., Gratwick K., Meador C., Hansen C., Tibbetts C., Stenger D.A., Irvine M., Seto D., Purkayastha A., Freed N.E., Gibson M.G., Russell K., Metzgar D. Co-infections of adenovirus species in previously vaccinated patients. Emerg. Infect. Dis. 2006, 12:921-930.
110. Walsh M.P., Chintakuntlawar A., Robinson C.M., Madisch I., Harrach B., Hudson N.R., Schnurr D., Heim A., Chodosh J., Seto D., Jones M.S. Evidence of molecular evolution driven by recombination events influencing tropism in a novel human adenovirus that causes epidemic keratoconjunctivitis. PLoS ONE 2009, 4:e5635.
111. Walsh M.P., Seto J., Jones M.S., Chodosh J., Xu W., Seto D. Computational analysis identifies human adenovirus type 55 as a re-emergent acute respiratory disease pathogen. J. Clin. Microbiol. 2010, 48:991-993.
112. Whyte P., Buchkovich K.J., Horowitz J.M., Friend S.H., Raybuck M., Weinberg R.A., Harlow E. Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 1988, 334:124-129.
113. Wickham T.J., Mathias P., Cheresh D.A., Nemerow G.R. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 1993, 73:309-319.
114. Wiethoff C.M., Wodrich H., Gerace L., Nemerow G.R. Adenovirus protein VI mediates membrane disruption following capsid disassembly. J. Virol. 2005, 79:1992-2000.
115. Wigand R. Pitfalls in the identification of adenoviruses. J. Virol. Methods 1987, 16:161-169.
116. Wigand R., Fliedner D. Serologically intermediate adenovirus strains: a regular feature of group II adenoviruses. Arch. Gesamte Virusforsch. 1968, 24:245-256.
117. Wigand R., Keller D., Werling I. Immunological relationship among human adenoviruses of subgenus D. Arch. Virol. 1982, 72:199-209.
118. Williams J.F., Ustacelebi S. Complementation and recombination with temperature-sensitive mutants of adenovirus type 5. J. Gen. Virol. 1971, 13:345-348.
119. Williams J.F., Gharpure M., Ustacelebi S., McDonald S. Isolation of temperature-sensitive mutants of adenovirus type 5. J. Gen. Virol. 1971, 11:95-101.
120. Williams J., Grodzicker T., Sharp P., Sambrook J. Adenovirus recombination: physical mapping of crossover events. Cell 1975, 4:113-119.
121. Williams J., Young H., Austin P. Complementation of human adenovirus type 5 ts mutants by human adenovirus type 12. J. Virol. 1975, 15:675-678.
122. Wood D.J. Adenovirus gastroenteritis. Br. Med. J. (Clin. Res. Ed.) 1988, 296:229-230.
123. Wu E., Pache L., Von Seggern D.J., Mullen T.M., Mikyas Y., Stewart P.L., Nemerow G.R. Flexibility of the adenovirus fiber is required for efficient receptor interaction. J. Virol. 2003, 77:7225-7235.
124. Wu E., Trauger S.A., Pache L., Mullen T.M., von Seggern D.J., Siuzdak G., Nemerow G.R. Membrane cofactor protein is a receptor for adenoviruses associated with epidemic keratoconjunctivitis. J. Virol. 2004, 78:3897-3905.
125. Young C.S., Silverstein S.J. The kinetics of adenovirus recombination in homotypic and heterotypic genetic crosses. Virology 1980, 101:503-515.
126. Young C.S., Cachianes G., Munz P., Silverstein S. Replication and recombination in adenovirus-infected cells are temporally and functionally related. J. Virol. 1984, 51:571-577.
127. Zubieta C., Schoehn G., Chroboczek J., Cusack S. The structure of the human adenovirus 2 penton. Mol. Cell. 2005, 17:121-135.